ADMS
Adamas Pharmaceuticals, Inc.
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
72 hedge funds and large institutions have $44.8M invested in Adamas Pharmaceuticals, Inc. in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 28 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
72
Holders Change
-7
Holders Change %
-8.86%
% of All Funds
1.59%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
9
Increased
24
Reduced
28
Closed
13
Calls
$584K
Puts
$51K
Net Calls
+$533K
Net Calls Change
-$427K
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
$7.92M |
| 2 |
Morgan Stanley
New York
|
$1.49M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
$626K |
| 4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
$454K |
| 5 |
JPMorgan Chase & Co
New York
|
$443K |
